scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding scPharmaceuticals Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 95 | +19 |
| Shares | 27.8M | 1.77M | 37.3M | +11.2M (+43.0%) |
| Value | $121.0M | $7.69M | $169.8M | +$56.5M (+49.9%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (6)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Bank of Montreal | 351,806 | $1.54M |
| Kennedy Capital Management, Inc. | 218,812 | $951.8K |
| Assenagon Asset Management S.A. | 72,692 | $316.2K |
| Squarepoint Ops LLC | 19,554 | $85.1K |
| Trexquant Investment LP | 13,995 | $60.9K |
| Massmutual Trust Co FSB | 389 | $1.69K |
Not filed for Q3 2024 yet (1)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,768,669 | $7.69M |